{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:25:46Z","timestamp":1794104746286,"version":"4.8.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007834","name":"Ningbo Natural Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03134-2","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T22:11:15Z","timestamp":1737670275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Recent advances of anti-tumor nano-strategies via overturning pH gradient: alkalization and acidification"],"prefix":"10.1186","volume":"23","author":[{"given":"Qiufang","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixuan","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"issue":"45","key":"3134_CR1","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27(45):5904\u201312.","journal-title":"Oncogene"},{"key":"3134_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","volume":"82","author":"E Boedtkjer","year":"2020","unstructured":"Boedtkjer E, Pedersen SF. The acidic Tumor Microenvironment as a driver of Cancer. Annu Rev Physiol. 2020;82:103\u201326.","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"3134_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/nsr\/nwx062","volume":"5","author":"LZ Feng","year":"2018","unstructured":"Feng LZ, et al. The acidic tumor microenvironment: a target for smart cancer nano-theranostics. Natl Sci Rev. 2018;5(2):269\u201386.","journal-title":"Natl Sci Rev"},{"key":"3134_CR4","doi-asserted-by":"publisher","first-page":"p113806","DOI":"10.1016\/j.ejmech.2021.113806","volume":"226","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1. Eur J Med Chem. 2021;226:p113806.","journal-title":"Eur J Med Chem"},{"key":"3134_CR5","doi-asserted-by":"publisher","first-page":"103627","DOI":"10.1016\/j.ebiom.2021.103627","volume":"73","author":"ZH Wang","year":"2021","unstructured":"Wang ZH, et al. Lactate in the tumour microenvironment: from immune modulation to therapy. Ebiomedicine. 2021;73:103627.","journal-title":"Ebiomedicine"},{"issue":"16","key":"3134_CR6","doi-asserted-by":"publisher","first-page":"13815","DOI":"10.1074\/jbc.M111.219899","volume":"286","author":"A Hulikova","year":"2011","unstructured":"Hulikova A, Vaughan-Jones RD, Swietach P. Dual role of CO2\/HCO3 buffer in the regulation of intracellular pH of three-dimensional Tumor growths. J Biol Chem. 2011;286(16):13815\u201326.","journal-title":"J Biol Chem"},{"issue":"6","key":"3134_CR7","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1158\/0008-5472.CAN-07-5575","volume":"69","author":"IF Robey","year":"2009","unstructured":"Robey IF, et al. Bicarbonate increases Tumor pH and inhibits spontaneous metastases. Cancer Res. 2009;69(6):2260\u20138.","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"3134_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10555-018-09777-y","volume":"38","author":"O Thews","year":"2019","unstructured":"Thews O, Riemann A. Tumor pH and metastasis: a malignant process beyond hypoxia. Cancer Metastasis Rev. 2019;38(1\u20132):113\u201329.","journal-title":"Cancer Metastasis Rev"},{"issue":"10","key":"3134_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc.2017.77","volume":"17","author":"C Corbet","year":"2017","unstructured":"Corbet C, Feron O. Tumour acidosis: from the passenger to the driver\u2019s seat. Nat Rev Cancer. 2017;17(10):577\u201393.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"3134_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2967\/jnumed.109.068981","volume":"51","author":"XM Zhang","year":"2010","unstructured":"Zhang XM, Lin YX, Gillies RJ. Tumor pH and its measurement. J Nucl Med. 2010;51(8):1167\u201370.","journal-title":"J Nucl Med"},{"issue":"39","key":"3134_CR11","doi-asserted-by":"publisher","first-page":"22182","DOI":"10.1039\/C8RA02095G","volume":"8","author":"GY Hao","year":"2018","unstructured":"Hao GY, Xu ZP, Li L. Manipulating extracellular tumour pH: an effective target for cancer therapy. RSC Adv. 2018;8(39):22182\u201392.","journal-title":"RSC Adv"},{"issue":"12","key":"3134_CR12","first-page":"1511","volume":"29","author":"F Baltazar","year":"2014","unstructured":"Baltazar F, et al. Monocarboxylate transporters as targets and mediators in cancer therapy response. Histol Histopathol. 2014;29(12):1511\u201324.","journal-title":"Histol Histopathol"},{"issue":"11","key":"3134_CR13","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41417-022-00477-y","volume":"29","author":"FQ Chen","year":"2022","unstructured":"Chen FQ, et al. The V-ATPases in cancer and cell death. Cancer Gene Ther. 2022;29(11):1529\u201341.","journal-title":"Cancer Gene Ther"},{"key":"3134_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","volume":"33","author":"VL Payen","year":"2020","unstructured":"Payen VL, et al. Monocarboxylate transporters in cancer. Mol Metabolism. 2020;33:48\u201366.","journal-title":"Mol Metabolism"},{"issue":"13","key":"3134_CR15","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1158\/0008-5472.CAN-15-1862","volume":"76","author":"A McIntyre","year":"2016","unstructured":"McIntyre A, et al. Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and suppresses Tumor Growth. Cancer Res. 2016;76(13):3744\u201355.","journal-title":"Cancer Res"},{"issue":"15","key":"3134_CR16","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.3390\/ijms20153694","volume":"20","author":"RA Cardone","year":"2019","unstructured":"Cardone RA, et al. The role of Sodium Hydrogen Exchanger 1 in Dysregulation of Proton Dynamics and Reprogramming of Cancer Metabolism as a Sequela. Int J Mol Sci. 2019;20(15):3694.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3134_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/metabo8010019","volume":"8","author":"MY Mboge","year":"2018","unstructured":"Mboge MY, et al. Carbonic anhydrases: role in pH control and Cancer. Metabolites. 2018;8(1):19.","journal-title":"Metabolites"},{"issue":"2","key":"3134_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41416-019-0642-z","volume":"122","author":"HM Becker","year":"2020","unstructured":"Becker HM. Carbonic anhydrase IX and acid transport in cancer. Br J Cancer. 2020;122(2):157\u201367.","journal-title":"Br J Cancer"},{"issue":"1\u20132","key":"3134_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","volume":"38","author":"S Pastorekova","year":"2019","unstructured":"Pastorekova S, Gillies RJ. The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond. Cancer Metastasis Rev. 2019;38(1\u20132):65\u201377.","journal-title":"Cancer Metastasis Rev"},{"issue":"8","key":"3134_CR20","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/s41388-019-1098-6","volume":"39","author":"S Ames","year":"2020","unstructured":"Ames S, et al. Carbonic anhydrase IX forms a transport metabolon with monocarboxylate transporters in human breast cancer. Oncogene. 2020;39(8):1710\u201323.","journal-title":"Oncogene"},{"issue":"6","key":"3134_CR21","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.3390\/ijms22063171","volume":"22","author":"HM Becker","year":"2021","unstructured":"Becker HM, Deitmer JW. Proton Transport in Cancer cells: the role of Carbonic anhydrases. Int J Mol Sci. 2021;22(6):3171.","journal-title":"Int J Mol Sci"},{"key":"3134_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.drup.2015.08.004","volume":"23","author":"S Taylor","year":"2015","unstructured":"Taylor S, et al. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach. Drug Resist Updates. 2015;23:69\u201378.","journal-title":"Drug Resist Updates"},{"issue":"21","key":"3134_CR23","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.3390\/ijms21218363","volume":"21","author":"JX Wang","year":"2020","unstructured":"Wang JX, et al. Lactic acid and an acidic Tumor Microenvironment suppress Anticancer Immunity. Int J Mol Sci. 2020;21(21):8363.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3134_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai S, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022;40(2):201.","journal-title":"Cancer Cell"},{"issue":"1","key":"3134_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s11671-021-03628-6","volume":"16","author":"S Gavas","year":"2021","unstructured":"Gavas S, Quazi S, Karpinski TM. Nanoparticles for Cancer Therapy: current Progress and challenges. Nanoscale Res Lett. 2021;16(1):173.","journal-title":"Nanoscale Res Lett"},{"issue":"1","key":"3134_CR26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/molecules27010146","volume":"27","author":"M Kenchegowda","year":"2022","unstructured":"Kenchegowda M, et al. Smart Nanocarriers as an emerging platform for Cancer Therapy: a review. Molecules. 2022;27(1):146.","journal-title":"Molecules"},{"issue":"12","key":"3134_CR27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nnano.2007.387","volume":"2","author":"D Peer","year":"2007","unstructured":"Peer D, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751\u201360.","journal-title":"Nat Nanotechnol"},{"key":"3134_CR28","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.2147\/IJN.S366187","volume":"17","author":"WT Chen","year":"2022","unstructured":"Chen WT, et al. Research Progress on improving the efficiency of CDT by exacerbating Tumor Acidification. Int J Nanomed. 2022;17:2611\u201328.","journal-title":"Int J Nanomed"},{"key":"3134_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.nantod.2018.08.007","volume":"22","author":"J Jin","year":"2018","unstructured":"Jin J, Ovais M, Chen CY. Stimulus-responsive gold nanotheranostic platforms for targeting the tumor microenvironment. Nano Today. 2018;22:83\u201399.","journal-title":"Nano Today"},{"issue":"7","key":"3134_CR30","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1158\/2326-6066.CIR-18-0657","volume":"7","author":"SC Chafe","year":"2019","unstructured":"Chafe SC, et al. Targeting Hypoxia-Induced Carbonic anhydrase IX enhances Immune-Checkpoint Blockade locally and systemically. Cancer Immunol Res. 2019;7(7):1064\u201378.","journal-title":"Cancer Immunol Res"},{"key":"3134_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jconrel.2014.12.018","volume":"201","author":"IA Khawar","year":"2015","unstructured":"Khawar IA, Kim JH, Kuh HJ. Improving drug delivery to solid tumors: priming the tumor microenvironment. J Controlled Release. 2015;201:78\u201389.","journal-title":"J Controlled Release"},{"key":"3134_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","volume":"387","author":"T Wu","year":"2017","unstructured":"Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017;387:61\u20138.","journal-title":"Cancer Lett"},{"issue":"42","key":"3134_CR33","doi-asserted-by":"publisher","first-page":"18556","DOI":"10.1002\/anie.202005362","volume":"59","author":"Q Cao","year":"2020","unstructured":"Cao Q, et al. Highly potent platinum(IV) Prodrugs Selective against Carbonic anhydrase IX for the Treatment of Hypoxic Tumors. Angewandte Chemie-International Ed. 2020;59(42):18556\u201362.","journal-title":"Angewandte Chemie-International Ed"},{"key":"3134_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-016-0555-x","volume":"15","author":"A Deshmukh","year":"2016","unstructured":"Deshmukh A, et al. Cancer stem cell metabolism: a potential target for cancer therapy. Mol Cancer. 2016;15:1\u201310.","journal-title":"Mol Cancer"},{"issue":"6","key":"3134_CR35","first-page":"3752","volume":"40","author":"YS Ko","year":"2018","unstructured":"Ko YS, et al. Radioresistant breast cancer cells exhibit increased resistance to chemotherapy and enhanced invasive properties due to cancer stem cells. Oncol Rep. 2018;40(6):3752\u201362.","journal-title":"Oncol Rep"},{"issue":"1","key":"3134_CR36","first-page":"5416923","volume":"2018","author":"LTH Phi","year":"2018","unstructured":"Phi LTH, et al. Cancer Stem cells (CSCs) in Drug Resistance and their therapeutic implications in Cancer Treatment. Stem Cells Int. 2018;2018(1):5416923.","journal-title":"Stem Cells Int"},{"issue":"38","key":"3134_CR37","doi-asserted-by":"publisher","first-page":"p2302916","DOI":"10.1002\/adma.202302916","volume":"35","author":"Q Wang","year":"2023","unstructured":"Wang Q, et al. Cancer Stem-Like cells-oriented Surface Self-Assembly to conquer Radioresistance. Adv Mater. 2023;35(38):p2302916.","journal-title":"Adv Mater"},{"key":"3134_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jconrel.2015.08.050","volume":"219","author":"JZ Du","year":"2015","unstructured":"Du JZ, Lane LA, Nie SM. Stimuli-responsive nanoparticles for targeting the tumor microenvironment. J Controlled Release. 2015;219:205\u201314.","journal-title":"J Controlled Release"},{"issue":"5","key":"3134_CR39","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1039\/C5CS00798D","volume":"45","author":"M Karimi","year":"2016","unstructured":"Karimi M, et al. Smart micro\/nanoparticles in stimulus-responsive drug\/gene delivery systems. Chem Soc Rev. 2016;45(5):1457\u2013501.","journal-title":"Chem Soc Rev"},{"issue":"10","key":"3134_CR40","doi-asserted-by":"publisher","first-page":"1800917","DOI":"10.1002\/marc.201800917","volume":"40","author":"N Deirram","year":"2019","unstructured":"Deirram N, et al. pH-Responsive polymer nanoparticles for drug delivery. Macromol Rapid Commun. 2019;40(10):1800917.","journal-title":"Macromol Rapid Commun"},{"issue":"25","key":"3134_CR41","doi-asserted-by":"publisher","first-page":"2300060","DOI":"10.1002\/smll.202300060","volume":"19","author":"K Zhang","year":"2023","unstructured":"Zhang K, et al. Self-disguised nanospy for improving drug delivery efficiency via decreasing. Small. 2023;19(25):2300060.","journal-title":"Small"},{"key":"3134_CR42","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jconrel.2022.11.006","volume":"352","author":"Y Yan","year":"2022","unstructured":"Yan Y, et al. Peritumoral scaffold neutralizes tumor pH for chemotherapy sensitization and metastasis inhibition. J Controlled Release. 2022;352:747\u201358.","journal-title":"J Controlled Release"},{"key":"3134_CR43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2017.03.001","volume":"43","author":"V Huber","year":"2017","unstructured":"Huber V, et al. Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of immunomodulation. Sem Cancer Biol. 2017;43:74\u201389.","journal-title":"Sem Cancer Biol"},{"issue":"6","key":"3134_CR44","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1158\/0008-5472.CAN-15-1743","volume":"76","author":"S Pilon-Thomas","year":"2016","unstructured":"Pilon-Thomas S, et al. Neutralization of Tumor Acidity improves antitumor responses to Immunotherapy. Cancer Res. 2016;76(6):1381\u201390.","journal-title":"Cancer Res"},{"issue":"9","key":"3134_CR45","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00262-018-2195-z","volume":"67","author":"R Lacroix","year":"2018","unstructured":"Lacroix R, et al. Targeting tumor-associated acidity in cancer immunotherapy. Cancer Immunol Immunotherapy. 2018;67(9):1331\u201348.","journal-title":"Cancer Immunol Immunotherapy"},{"key":"3134_CR46","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.nantod.2023.102146","volume":"54","author":"K Fan","year":"2024","unstructured":"Fan K, et al. Acidic tumor microenvironment-activated MRI nanoprobes for modulation and visualization of anti-PD-L1 immunotherapy. Nano Today. 2024;54:102146.","journal-title":"Nano Today"},{"issue":"32","key":"3134_CR47","doi-asserted-by":"publisher","first-page":"2304092","DOI":"10.1002\/advs.202304092","volume":"10","author":"R Qian","year":"2023","unstructured":"Qian R, et al. Regulation of Ion Homeostasis for enhanced Tumor Radio-Immunotherapy. Adv Sci. 2023;10(32):2304092.","journal-title":"Adv Sci"},{"issue":"3","key":"3134_CR48","doi-asserted-by":"publisher","first-page":"C392","DOI":"10.1152\/ajpcell.00442.2020","volume":"320","author":"AF Eaton","year":"2021","unstructured":"Eaton AF, Merkulova M, Brown D. The H-ATPase (V-ATPase): from proton pump to signaling complex in health and disease. Am J Physiology-Cell Physiol. 2021;320(3):C392\u2013414.","journal-title":"Am J Physiology-Cell Physiol"},{"issue":"1","key":"3134_CR49","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1039\/C8RA08924H","volume":"9","author":"S Bhattacharya","year":"2019","unstructured":"Bhattacharya S, et al. A chemotherapeutic approach targeting the acidic tumor microenvironment: combination of a proton pump inhibitor and paclitaxel for statistically optimized nanotherapeutics. RSC Adv. 2019;9(1):240\u201354.","journal-title":"RSC Adv"},{"issue":"21","key":"3134_CR50","doi-asserted-by":"publisher","first-page":"p2300216","DOI":"10.1002\/adma.202300216","volume":"35","author":"Y Li","year":"2023","unstructured":"Li Y, et al. A hierarchical structured Fiber device remodeling the acidic tumor microenvironment for enhanced Cancer Immunotherapy. Adv Mater. 2023;35(21):2300216.","journal-title":"Adv Mater"},{"key":"3134_CR51","doi-asserted-by":"crossref","unstructured":"Gao YT et al. Tumor Microenvironment: Lactic Acid Promotes Tumor Development. Journal Of Immunology Research. 2022;2022:3119375.","DOI":"10.1155\/2022\/3119375"},{"issue":"4","key":"3134_CR52","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/cancers11040450","volume":"11","author":"S Daneshmandi","year":"2019","unstructured":"Daneshmandi S, Wegiel B, Seth P. Blockade of Lactate Dehydrogenase-A (LDH-A) improves efficacy of Anti-programmed Cell Death-1 (PD-1) therapy in Melanoma. Cancers. 2019;11(4):450.","journal-title":"Cancers"},{"issue":"23","key":"3134_CR53","doi-asserted-by":"publisher","first-page":"8552","DOI":"10.3390\/molecules27238552","volume":"27","author":"H Wang","year":"2022","unstructured":"Wang H, et al. SnSe Nanosheets Mimic Lactate dehydrogenase to reverse Tumor Acid Microenvironment Metabolism for Enhancement of Tumor Therapy. Molecules. 2022;27(23):8552.","journal-title":"Molecules"},{"issue":"5","key":"3134_CR54","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1021\/acs.nanolett.8b04296","volume":"19","author":"YX Zhang","year":"2019","unstructured":"Zhang YX, et al. Nanoenabled Modulation of Acidic Tumor Microenvironment reverses Anergy of infiltrating T cells and potentiates Anti-PD-1 therapy. Nano Lett. 2019;19(5):2774\u201383.","journal-title":"Nano Lett"},{"key":"3134_CR55","doi-asserted-by":"crossref","unstructured":"Ye CQ et al. Effects of Attractive Pickering emulsion gels loaded with oxaliplatin and lactate dehydrogenase inhibitors in hepatocellular carcinoma. Journal Of Clinical Oncology. 2024;42(16):110519.","DOI":"10.1200\/JCO.2024.42.16_suppl.e16235"},{"key":"3134_CR56","doi-asserted-by":"crossref","unstructured":"Wu XM et al. Glutathione Induced in situ activation of dual-locked cuproptosis nanoamplifier with glycolysis metabolism inhibition to Boost Cancer Immunotherapy. Adv Healthc Mater, 2024: p.2403380.","DOI":"10.1002\/adhm.202403380"},{"key":"3134_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2019.01.004","volume":"296","author":"H Abumanhal-Masarweh","year":"2019","unstructured":"Abumanhal-Masarweh H, et al. Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin. J Controlled Release. 2019;296:1\u201313.","journal-title":"J Controlled Release"},{"issue":"40","key":"3134_CR58","doi-asserted-by":"publisher","first-page":"e202307706","DOI":"10.1002\/anie.202307706","volume":"62","author":"BB Ding","year":"2023","unstructured":"Ding BB, et al. Sodium bicarbonate nanoparticles for Amplified Cancer Immunotherapy by inducing pyroptosis and regulating Lactic Acid Metabolism. Angewandte Chemie-International Ed. 2023;62(40):e202307706.","journal-title":"Angewandte Chemie-International Ed"},{"key":"3134_CR59","doi-asserted-by":"publisher","first-page":"151838","DOI":"10.1016\/j.cej.2024.151838","volume":"490","author":"WG Chen","year":"2024","unstructured":"Chen WG, et al. Amorphous CaCO3-bioreactor for tumor microenvironment regulation to reinforce tumor chemoimmunotherapy. Chem Eng J. 2024;490:151838.","journal-title":"Chem Eng J"},{"issue":"1","key":"3134_CR60","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s12951-023-01934-y","volume":"21","author":"SR Ruan","year":"2023","unstructured":"Ruan SR, et al. Acidic and hypoxic tumor microenvironment regulation by CaO3-loaded polydopamine nanoparticles (20, 544, 2022). J Nanobiotechnol. 2023;21(1):544.","journal-title":"J Nanobiotechnol"},{"key":"3134_CR61","doi-asserted-by":"crossref","unstructured":"Gao YH et al. Enhanced Osteosarcoma Immunotherapy via CaCO3 nanoparticles: Remodeling Tumor Acidic and Immune Microenvironment for photodynamic therapy. Adv Healthc Mater, 2024:p. 2400538.","DOI":"10.1002\/adhm.202400538"},{"issue":"9","key":"3134_CR62","doi-asserted-by":"publisher","first-page":"2308254","DOI":"10.1002\/adma.202308254","volume":"36","author":"ZL Dong","year":"2024","unstructured":"Dong ZL, et al. Tumor Microenvironment modulating CaCO3-Based Colloidosomal Microreactors can generally reinforce Cancer Immunotherapy. Adv Mater. 2024;36(9):2308254.","journal-title":"Adv Mater"},{"issue":"25","key":"3134_CR63","doi-asserted-by":"publisher","first-page":"12639","DOI":"10.1039\/C5NR06162H","volume":"8","author":"A Som","year":"2016","unstructured":"Som A, et al. Monodispersed calcium carbonate nanoparticles modulate local pH and inhibit tumor growth. Nanoscale. 2016;8(25):12639\u201347.","journal-title":"Nanoscale"},{"issue":"9","key":"3134_CR64","doi-asserted-by":"publisher","first-page":"13884","DOI":"10.1021\/acsnano.2c02688","volume":"16","author":"ZL Dong","year":"2022","unstructured":"Dong ZL, et al. Chemical Modulation of glucose metabolism with a fluorinated CaCO3 Nanoregulator can Potentiate Radiotherapy by Programming Antitumor Immunity. ACS Nano. 2022;16(9):13884\u201399.","journal-title":"ACS Nano"},{"issue":"37","key":"3134_CR65","doi-asserted-by":"publisher","first-page":"2301420","DOI":"10.1002\/smll.202301420","volume":"19","author":"Y Ding","year":"2023","unstructured":"Ding Y, et al. Construction of pH-Sensitive nanovaccines encapsulating tumor cell lysates and Immune adjuvants for breast Cancer therapy. Small. 2023;19(37):2301420.","journal-title":"Small"},{"issue":"1","key":"3134_CR66","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","volume":"14","author":"Q Chen","year":"2019","unstructured":"Chen Q, et al. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment. Nat Nanotechnol. 2019;14(1):89\u201397.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"3134_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40820-020-00549-4","volume":"13","author":"YJ Zhu","year":"2021","unstructured":"Zhu YJ, et al. CaCO3-Assisted Preparation of pH-Responsive Immune-modulating nanoparticles for augmented chemo-immunotherapy. Nano-Micro Lett. 2021;13(1):1\u201318.","journal-title":"Nano-Micro Lett"},{"issue":"1","key":"3134_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-021-01057-2","volume":"19","author":"LH Li","year":"2021","unstructured":"Li LH, et al. Biodegradable mesoporous manganese carbonate nanocomposites for LED light-driven cancer therapy via enhancing photodynamic therapy and attenuating survivin expression. J Nanobiotechnol. 2021;19(1):1\u201314.","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"3134_CR69","doi-asserted-by":"publisher","first-page":"100853","DOI":"10.1016\/j.ajps.2023.100853","volume":"18","author":"C Lee","year":"2023","unstructured":"Lee C. Targeted hyperalkalization with NaOH-loaded starch implants enhances doxorubicin efficacy in tumor treatment. Asian J Pharm Sci. 2023;18(5):100853.","journal-title":"Asian J Pharm Sci"},{"issue":"25","key":"3134_CR70","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1039\/D3TB00227F","volume":"11","author":"F Zhou","year":"2023","unstructured":"Zhou F, et al. A calcium hydroxide\/oleic acid\/phospholipid nanoparticle induced cancer cell apoptosis by the combination of intracellular calcium overload and lactic acidosis elimination. J Mater Chem B. 2023;11(25):5856\u201369.","journal-title":"J Mater Chem B"},{"issue":"8","key":"3134_CR71","doi-asserted-by":"publisher","first-page":"12036","DOI":"10.1021\/acsnano.2c02183","volume":"16","author":"LX Zhang","year":"2022","unstructured":"Zhang LX, et al. Efficient immunotherapy of drug-free layered double hydroxide nanoparticles via neutralizing excess acid and blocking Tumor Cell Autophagy. ACS Nano. 2022;16(8):12036\u201348.","journal-title":"ACS Nano"},{"key":"3134_CR72","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2147\/IJN.S440387","volume":"19","author":"YL Wang","year":"2024","unstructured":"Wang YL, et al. Synergistic effects of Nanoscale CaO2 combined with PD-1 inhibitors in the Treatment of Hepatocellular Carcinoma: a promising combination. Int J Nanomed. 2024;19:137\u201354.","journal-title":"Int J Nanomed"},{"issue":"6","key":"3134_CR73","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1021\/acsabm.0c00383","volume":"3","author":"H Liao","year":"2020","unstructured":"Liao H, et al. Three birds with one stone: injectable CaC2 nanobombs with triple effects for minimally invasive tumor chemical ablation. ACS Appl Bio Mater. 2020;3(6):3809\u201316.","journal-title":"ACS Appl Bio Mater"},{"key":"3134_CR74","doi-asserted-by":"crossref","unstructured":"Prasad P et al. Multifunctional Albumin-MnO2 Nanoparticles Modulate Solid Tumor Microenvironment by Attenuating Hypoxia, Acidosis, Vascular Endothelial Growth Factor and Enhance Radiation Response (2014). Acs Nano. 2014;8(6):6510\u20136510.","DOI":"10.1021\/nn502569e"},{"issue":"4","key":"3134_CR75","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/cancers12040891","volume":"12","author":"NCS Voss","year":"2020","unstructured":"Voss NCS, et al. Targeting the acidic Tumor Microenvironment: unexpected Pro-neoplastic effects of oral NaHCO3 therapy in murine breast tissue. Cancers. 2020;12(4):891.","journal-title":"Cancers"},{"issue":"5","key":"3134_CR76","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.3892\/ol.2016.5112","volume":"12","author":"YH Yuan","year":"2016","unstructured":"Yuan YH, et al. NaHCO3 enhances the antitumor activities of cytokine-induced killer cells against hepatocellular carcinoma HepG2 cells. Oncol Lett. 2016;12(5):3167\u201374.","journal-title":"Oncol Lett"},{"issue":"2","key":"3134_CR77","doi-asserted-by":"publisher","first-page":"100905","DOI":"10.1016\/j.ajps.2024.100905","volume":"19","author":"XJ Guo","year":"2024","unstructured":"Guo XJ, et al. Acidic\/hypoxia dual-alleviated nanoregulators for enhanced treatment of tumor chemo-immunotherapy. Asian J Pharm Sci. 2024;19(2):100905.","journal-title":"Asian J Pharm Sci"},{"issue":"2","key":"3134_CR78","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/pharmaceutics16020275","volume":"16","author":"CT Lin","year":"2024","unstructured":"Lin CT, et al. Recent developments in CaCO3 Nano-Drug Delivery systems: advancing Biomedicine in Tumor diagnosis and treatment. Pharmaceutics. 2024;16(2):275.","journal-title":"Pharmaceutics"},{"issue":"11","key":"3134_CR79","first-page":"19106","volume":"4","author":"WY Wong","year":"2016","unstructured":"Wong WY, et al. Urease-mediated alkalization of tumor microenvironment and its effects on T cell proliferation, cytokine release, and PD1\/PD-L1 interactions. Cancer Immunol Res. 2016;4(11):19106\u20134404.","journal-title":"Cancer Immunol Res"},{"issue":"7","key":"3134_CR80","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/sj.bjc.6690455","volume":"80","author":"N Raghunand","year":"1999","unstructured":"Raghunand N, et al. Enhancement of chemotherapy by manipulation of tumour pH. Br J Cancer. 1999;80(7):1005\u201311.","journal-title":"Br J Cancer"},{"issue":"14","key":"3134_CR81","doi-asserted-by":"publisher","first-page":"6126","DOI":"10.1039\/D2CS00236A","volume":"51","author":"TT Hu","year":"2022","unstructured":"Hu TT, et al. Layered double hydroxide-based nanomaterials for biomedical applications. Chem Soc Rev. 2022;51(14):6126\u201376.","journal-title":"Chem Soc Rev"},{"issue":"3","key":"3134_CR82","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/eem2.12116","volume":"3","author":"C Jing","year":"2020","unstructured":"Jing C, Dong BQ, Zhang YX. Chemical modifications of layered double hydroxides in the Supercapacitor. Energy Environ Mater. 2020;3(3):346\u201379.","journal-title":"Energy Environ Mater"},{"issue":"1","key":"3134_CR83","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1038\/s41467-022-31106-9","volume":"13","author":"WC Shen","year":"2022","unstructured":"Shen WC, et al. Defect engineering of layered double hydroxide nanosheets as inorganic photosensitizers for NIR-III photodynamic cancer therapy. Nat Commun. 2022;13(1):3384.","journal-title":"Nat Commun"},{"issue":"2","key":"3134_CR84","first-page":"27","volume":"5","author":"MP Nikolova","year":"2020","unstructured":"Nikolova MP, Chavali MS. Metal Oxide Nanopart as Biomedical Mater Biomimetics. 2020;5(2):27.","journal-title":"Metal Oxide Nanopart as Biomedical Mater Biomimetics"},{"key":"3134_CR85","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijbiomac.2021.12.190","volume":"201","author":"I Koyuncu","year":"2022","unstructured":"Koyuncu I, et al. Intracellular pH-mediated induction of apoptosis in HeLa cells by a sulfonamide carbonic anhydrase inhibitor. Int J Biol Macromol. 2022;201:37\u201346.","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"3134_CR86","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.3390\/ijms22116098","volume":"22","author":"E Temiz","year":"2021","unstructured":"Temiz E, et al. Inhibition of Carbonic anhydrase IX promotes apoptosis through intracellular pH level alterations in Cervical Cancer cells. Int J Mol Sci. 2021;22(11):6098.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3134_CR87","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1080\/14756366.2022.2052868","volume":"37","author":"M Kciuk","year":"2022","unstructured":"Kciuk M, et al. Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies. J Enzyme Inhib Med Chem. 2022;37(1):1278\u201398.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"6","key":"3134_CR88","doi-asserted-by":"publisher","first-page":"p1908365","DOI":"10.1002\/adfm.201908365","volume":"30","author":"XY Chen","year":"2020","unstructured":"Chen XY, et al. Amorphous Fe-Based nanoagents for self-enhanced chemodynamic therapy by re-establishing Tumor Acidosis. Adv Funct Mater. 2020;30(6):p1908365.","journal-title":"Adv Funct Mater"},{"issue":"43","key":"3134_CR89","doi-asserted-by":"publisher","first-page":"19884","DOI":"10.1021\/jacs.2c07669","volume":"144","author":"JJ Wang","year":"2022","unstructured":"Wang JJ, et al. Biodegradable Ferrous Sulfide-based nanocomposites for Tumor Theranostics through specific Intratumoral Acidosis-Induced metabolic symbiosis disruption. J Am Chem Soc. 2022;144(43):19884\u201395.","journal-title":"J Am Chem Soc"},{"key":"3134_CR90","doi-asserted-by":"publisher","first-page":"148069","DOI":"10.1016\/j.cej.2023.148069","volume":"480","author":"Q Yao","year":"2024","unstructured":"Yao Q, et al. Modulation of glucose metabolism through macrophage-membrane-coated metal-organic framework nanoparticles for triple-negative breast cancer therapy. Chem Eng J. 2024;480:148069.","journal-title":"Chem Eng J"},{"issue":"46","key":"3134_CR91","doi-asserted-by":"publisher","first-page":"2304058","DOI":"10.1002\/smll.202304058","volume":"19","author":"JW Zhu","year":"2023","unstructured":"Zhu JW, et al. Acidity-responsive Nanoreactors destructed Warburg Effect for toxic-acidosis and starvation synergistic therapy. Small. 2023;19(46):2304058.","journal-title":"Small"},{"key":"3134_CR92","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.actbio.2023.03.036","volume":"164","author":"H Zhang","year":"2023","unstructured":"Zhang H, et al. An enzyme-instructed self-assembly system induces tumor acidosis via sequential-dual effect for cancer selective therapy. Acta Biomater. 2023;164:447\u201357.","journal-title":"Acta Biomater"},{"key":"3134_CR93","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.semcancer.2022.12.001","volume":"88","author":"C Heuser","year":"2023","unstructured":"Heuser C, et al. Targeting lactate metabolism for cancer immunotherapy-a matter of precision. Sem Cancer Biol. 2023;88:32\u201345.","journal-title":"Sem Cancer Biol"},{"issue":"7","key":"3134_CR94","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","volume":"16","author":"XY Li","year":"2019","unstructured":"Li XY, et al. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nat Reviews Clin Oncol. 2019;16(7):425\u201341.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"13","key":"3134_CR95","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1021\/jacs.2c12772","volume":"145","author":"CZ Yang","year":"2023","unstructured":"Yang CZ, et al. Heterostructural Nanoadjuvant CuSe\/CoSe2 for Potentiating Ferroptosis and Photoimmunotherapy through Intratumoral blocked Lactate Efflux. J Am Chem Soc. 2023;145(13):7205\u201317.","journal-title":"J Am Chem Soc"},{"issue":"6","key":"3134_CR96","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/anie.201710144","volume":"57","author":"YL Liu","year":"2018","unstructured":"Liu YL, et al. Engineering Multifunctional RNAi Nanomedicine to concurrently target Cancer Hallmarks for Combinatorial Therapy. Angewandte Chemie-International Ed. 2018;57(6):1510\u20133.","journal-title":"Angewandte Chemie-International Ed"},{"key":"3134_CR97","doi-asserted-by":"publisher","first-page":"101162","DOI":"10.1016\/j.nantod.2021.101162","volume":"39","author":"QW Tian","year":"2021","unstructured":"Tian QW, et al. Recent advances in enhanced chemodynamic therapy strategies. Nano Today. 2021;39:101162.","journal-title":"Nano Today"},{"key":"3134_CR98","doi-asserted-by":"publisher","first-page":"215004","DOI":"10.1016\/j.ccr.2022.215004","volume":"479","author":"SL Li","year":"2023","unstructured":"Li SL, et al. Recent advances in augmenting Fenton chemistry of nanoplatforms for enhanced chemodynamic therapy. Coord Chem Rev. 2023;479:215004.","journal-title":"Coord Chem Rev"},{"issue":"47","key":"3134_CR99","doi-asserted-by":"publisher","first-page":"2102269","DOI":"10.1002\/smll.202102269","volume":"17","author":"X Wang","year":"2021","unstructured":"Wang X, et al. Activatable Biomineralized Nanoplatform remodels the intracellular environment of Multidrug-Resistant Tumors for Enhanced Ferroptosis\/Apoptosis Therapy. Small. 2021;17(47):2102269.","journal-title":"Small"},{"issue":"10","key":"3134_CR100","doi-asserted-by":"publisher","first-page":"14164","DOI":"10.1021\/acsnano.0c07071","volume":"14","author":"K Li","year":"2020","unstructured":"Li K, et al. Engineering of Cascade-Responsive Nanoplatform to Inhibit Lactate Efflux for enhanced Tumor Chemo-Immunotherapy. ACS Nano. 2020;14(10):14164\u201380.","journal-title":"ACS Nano"},{"issue":"8","key":"3134_CR101","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1021\/acs.accounts.7b00190","volume":"50","author":"Y Liao","year":"2017","unstructured":"Liao Y, Design, Applications of Metastable-State Photoacids. Acc Chem Res. 2017;50(8):1956\u201364.","journal-title":"Acc Chem Res"},{"issue":"31","key":"3134_CR102","doi-asserted-by":"publisher","first-page":"10410","DOI":"10.1002\/anie.201810118","volume":"58","author":"N Zivic","year":"2019","unstructured":"Zivic N, et al. Recent advances and challenges in the design of Organic Photoacid and Photobase generators for polymerizations. Angewandte Chemie-International Ed. 2019;58(31):10410\u201322.","journal-title":"Angewandte Chemie-International Ed"},{"issue":"40","key":"3134_CR103","doi-asserted-by":"publisher","first-page":"21905","DOI":"10.1002\/anie.202107588","volume":"60","author":"XY Chen","year":"2021","unstructured":"Chen XY, et al. NIR-Triggered Intracellular H+ transients for Lamellipodia-collapsed antimetastasis and enhanced chemodynamic therapy. Angewandte Chemie-International Ed. 2021;60(40):21905\u201310.","journal-title":"Angewandte Chemie-International Ed"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03134-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03134-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03134-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T22:58:22Z","timestamp":1737673102000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03134-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3134"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03134-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}